Pneumologie 2023; 77(S 01): S90
DOI: 10.1055/s-0043-1761085
Dupilumab improves exacerbations and lung function irrespective of prior asthma exacerbations: TRAVERSE
M Lommatzsch
1
Universitätsklinikum Rostock; Zentrum für Innere Medizin; Abteilung für Pneumologie
,
A Papi
2
Respiratory Medicine Unit, University of Ferrara, S. Anna University Hospital, Ferrara, Italy
,
M Castro
3
University of Kansas School of Medicine, Kansas City, Ks
,
W Busse
4
Uw Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health
,
D Langton
5
Frankston Hospital
,
S Korn
6
Ikf Pneumologie Mainz; Clinical Research Centre Respiratory Diseases
,
C Xia
7
Regeneron Pharmaceuticals, Inc.
,
X Soler
7
Regeneron Pharmaceuticals, Inc.
,
N Pandit-Abid
8
Sanofi, Bridgewater, Nj, USA
,
S Siddiqui
7
Regeneron Pharmaceuticals, Inc.
,
J Jacob-Nara
9
Sanofi, Bridgewater, Nj
,
P Rowe
10
Sanofi
,
Y Deniz
11
Regeneron Pharmaceuticals, Inc., Tarrytown, Ny
› Author Affiliations